Vimal Mehta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vimal mehta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vimal Mehta Today - Breaking & Trending Today

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) CEO Vimal Mehta Sells 126,014 Shares

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares of the […] ....

United States , Vimal Mehta , Tower Research Capital , Truist Financial Corp , Virtu Financial , Canaccord Genuity Group , Bioxcel Therapeutics Company Profile , Apollon Wealth Management , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Get Free Report , Xcel Therapeutics Trading Down , Xcel Therapeutics , Wealth Management , Financial Corp , Research Capital , Pennant Investors , Bioxcel Therapeutics Daily ,

Insider Selling: BioXcel Therapeutics, Inc. (NASDAQ:BTAI) CEO Sells 126,014 Shares of Stock

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) CEO Vimal Mehta sold 126,014 shares of BioXcel Therapeutics stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $1.63, for a total transaction of $205,402.82. Following the transaction, the chief executive officer now directly owns 7,811,515 shares […] ....

United States , Vimal Mehta , Truist Financial Corp , Virtu Financial , Canaccord Genuity Group , York Mellon Corp , Bioxcel Therapeutics Inc , Apollon Wealth Management , Bioxcel Therapeutics , Get Free Report , Xcel Therapeutics Trading Down , Xcel Therapeutics , New York Mellon Corp , Financial Corp , Bioxcel Therapeutics Daily ,

BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference

28.05.2024 - NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) - BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced . Seite 1 ....

New York , United States , Vimal Mehta , Vincentj Oneill , Product Development , Drug Administration , Bioxcel Therapeutics Inc , Xcel Therapeutics , Jefferies Global Healthcare Conference , Bioxcel Therapeutic , Executive Vice President , Bioxcel Therapeutics , Breakthrough Therapy , Fast Track ,

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United States , Rob Risinger , Ram Selvaraju , Canaccord Genuity , Vimal Mehta , Sumant Kulkarni , Richard Steinhart , Avantika Joshi , Frank Yocca , Alec Stranahan , Matt Wiley , Colin Bristow , Vince Oneill , Vincent Oneill , Product Development , Bioxcel Therapeutics Inc , Trademark Office , Georgetown Lombardi Comprehensive Cancer Center , Most Profitable Companies , Bioxcel Therapeutics , Call Transcript May , Xcel Therapeutics , Bioxcel Therapeutics First Quarter , Chief Executive Officer , Vinceo Neill , Medical Officer ,

BioXcel Therapeutics Reports First Quarter 2024 Financial Results

BioXcel Therapeutics Reports First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Vimal Mehta , Scott Stachowiak , Brennan Doyle , David Schull , Erik Kopp , Securities Exchange , Aboutbioxceltherapeutics Inc , While The Company , Drug Administration , Bioxcel Therapeutics Inc , Development Rd Expenses , Xcel Therapeutics Reports First Quarter , Xcel Therapeutics , Post Marketing Requirement , United States Food , Napproved Drug Products , Therapeutic Equivalence Evaluations , Orange Book , Bioxcel Therapeutics , Breakthrough Therapy , Fast Track , Xcel Therapeutic , Orphan Drug Designation , Onkosxcel Therapeutics , Private Securities Litigation Reform Act ,